Bioresorbable Collagen Implant Market size is poised to cross USD 20 billion by the end of 2036, growing at a CAGR of 8% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of bioresorbable collagen implants was over USD 10 billion. Bioresorbable collagen implants are often used in aesthetic procedures such as facial fillers and lip augmentation. The growing demand for non-surgical cosmetic treatments could drive market growth. Collagen implants can be used in orthopedic surgeries, such as tendon and ligament repair. As the aging population increases and the incidence of sports-related injuries rises, the demand for these implants may also grow.
Bioresorbable collagen implants are medical devices used in various fields of medicine, including plastic surgery, orthopedics, and wound care. These implants are made from collagen, a protein found in connective tissues, and they are designed to gradually degrade and be absorbed by the body over time. This feature makes them useful for tissue repair and regeneration. Increasing awareness among both patients and healthcare providers about the benefits of bioresorbable collagen implants can contribute to market expansion. The bioresorbable collagen implant market refers to a specialized segment within the medical and healthcare industry that focuses on the development, manufacturing, and distribution of medical devices made from collagen-based materials. These implants are designed to be inserted into the human body to serve various therapeutic and cosmetic purposes, and they possess the unique characteristic of being biodegradable or bioresorbable.
Growth Drivers
Challenges
Base Year |
2023 |
Forecast Year |
2024-2036 |
CAGR |
~8% |
Base Year Market Size (2023) |
~ USD 10 Billion |
Forecast Year Market Size (2036) |
~ USD 20 Billion |
Regional Scope |
|
Type (Dermal Fillers, Orthopedic Implants)
The orthopedic implants segment is estimated to hold 61% share of the global bioresorbable collagen implant market by 2036. Bioresorbable collagen implants offer a minimally invasive approach for orthopedic procedures. Patients are more inclined toward procedures with quicker recovery, making collagen implants an attractive option. Minimally invasive surgeries are associated with shorter hospital stays and reduced recovery times, benefiting patients. Aging populations, advancements in implant technology, and a preference for minimally invasive procedures are driving demand for these products. Additionally, the alignment of collagen implants with regenerative medicine principles and their biocompatibility contribute to their increasing adoption in orthopedic applications.
End Users (Hospitals, Surgical Centers, Dermatology Clinics)
Bioresorbable collagen implant market from the hospitals segment is expected to garner a significant share in the year 2036. Hospitals are early adopters of innovative medical technologies, including bioresorbable collagen implants. Technological advancements in these implants improve patient outcomes, making hospitals more inclined to integrate them into their procedures. The global medical device sales are projected to reach USD 612 billion by the year 2027, driven by technological innovations. The hospitals segment is experiencing robust growth due to a combination of factors, including the increasing number of surgical procedures, technological advancements, and the growing demand for orthopedic, wound care, and aesthetic treatments. Hospitals, as key players in healthcare delivery, are actively adopting bioresorbable collagen implants to enhance patient outcomes and meet evolving medical needs.
Our in-depth analysis of the global market includes the following segments:
Type |
|
End User |
|
APAC Market Forecast
The bioresorbable collagen implant market in the Asia Pacific is projected to hold the largest revenue share of 37% by the end of 2036. Orthopedic surgeries often involve the use of bioresorbable collagen implants for tendon and ligament repair. The region's high incidence of trauma cases contributes to the growth of this segment. Orthopedic procedures account for a significant portion of surgical operations in the Asia-Pacific region, driven by trauma cases and sports injuries. The Asia Pacific region is experiencing robust growth in the market due to factors such as an aging population, increasing healthcare expenditure, a high volume of orthopedic procedures, and patient preferences for minimally invasive techniques and aesthetic enhancements. The alignment of collagen implants with these trends and the region's focus on safety and regulatory compliance further support market expansion.
North American Market Statistics
The bioresorbable collagen implant market in the North America region is projected to hold the second-largest share during the forecast period. An aging population is more susceptible to orthopedic conditions, such as osteoarthritis and ligament injuries. Bioresorbable collagen implants are increasingly used in orthopedic surgeries for tissue repair and regeneration, aligning with the needs of this demographic. North America has a rapidly aging population, with over 16% of its citizens aged 65 and older. North American hospitals and healthcare facilities are early adopters of innovative medical technologies, including bioresorbable collagen implants. Ongoing technological advancements in these implants enhance patient outcomes and drive market growth. The United States alone spends over 17% of its GDP on healthcare, promoting investments in advanced medical technologies.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?